BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageBRL-37344 is a b3-AR (b 3-adrenoceptor) selective agonist with lipolytic activity.
More Information Supplier PageBRL-37344 is a b3-AR (b 3-adrenoceptor) selective agonist with lipolytic activity.
More Information Supplier PageBRL-37344 is a b3-AR (b 3-adrenoceptor) selective agonist with lipolytic activity.
More Information Supplier PageHarringtonin is an alkaloid isolated from Cephalotaxus harringtonia, and an antitumor agent.
More Information Supplier PageHarringtonin is an alkaloid isolated from Cephalotaxus harringtonia, and an antitumor agent.
More Information Supplier PageHarringtonin is an alkaloid isolated from Cephalotaxus harringtonia, and an antitumor agent.
More Information Supplier PageEGFR inhibitor is a cell permeable, 4,6-disubstituted pyrimidine compound that selectively inhibits the EGFR kinase with an IC50 value of 21 nM in vitro and blocks receptor autophosphorylation in cells.
More Information Supplier PageBMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier Page
